CB2 Insights (CSE:CBII) CEO Pradyum Sekar recently spoke with Barrington Miller on the Canadian Securities Exchange #Hashtag Finance podcast to touch on the importance of validated cannabis data in the medical field. Sekar also spoke about the challenge of breaking down barriers with doctors and physicians as cannabis becomes more palatable for medical use.

According to Sekar, the type of data CB2 Insights is collecting is what sets the company apart in the medical cannabis space.


“What makes us unique is the fact that the data we collect is very much focused on what we consider to be validated medical efficacy outcome data. You’ve got a lot of patients currently using cannabis, it’s been an anecdotal industry for years. A lot of crowdsourced information, but the challenge in using that information in the medical sector if you’re a physician looking to treat your patient with cannabis is that it hasn’t been put through the same protocols and standardized measures that you can communicate clearly. It’s difficult to validate what the patients say they have, there is no standardized collection process or measurement process.”

Sekar also went on to explain the impact of big pharmaceutical companies in the medical cannabis space. According to Sekar, CB2 Insights is looking to pivot towards a vertically-integrated strategy following the company’s recent launch on the Canadian Securities Exchange.

To see the full interview click here.

Click here to connect with CB2 Insights (CSE:CBII) and to request an investor presentation. 

Both locations expand access to the state’s widest-ranging inventory of medical cannabis products for Central Florida patients

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of two brand-new Central Florida dispensaries. The new Clearwater and Tampa locations mark the Company’s 81 st and 82 nd nationwide, respectively, widening patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the appointment of Bart Oates Esq., President of the NFL Alumni Association, to its Advisory Board.

Philip Young, CEO and Director of Lobe, stated, “We are honored to welcome Bart to our Advisory Board. His first-hand experience on and off the field are tremendously valuable as we continue our research involving mild traumatic brain injuries and PTSD. These issues are prevalent in contact sports and we believe that athletes will play a prominent role in the continued acceptance of psychedelic medicines as legitimate treatment. We look forward to working with Bart as we seek to forge long-term strategic relationships.”

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has submitted its dossier to the United Kingdom’s Regulatory Food Safety Agency (the “FSA”).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005322/en/

Keep reading... Show less
  • MustGrow has isolated and concentrated a new mustard-derived extract, thiocyanate.
  • Thiocyanate is soil active and translocated in the plant as a systemic, non-selective bioherbicide (natural weed-killer).
  • Greenhouse weed treatment studies have commenced with this new bioherbicide extract.

MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce that it has isolated and concentrated an additional molecule, thiocyanate, from mustard seed. Thiocyanate, which is responsible for the systemic activity behind the mustard plant’s natural herbicidal (weed-killer) properties, is the third molecule from mustard seed that MustGrow has isolated, extracted, and concentrated. MustGrow had previously reported herbicidal proof-of-concept success without isolating thiocyanate and now expects to build on those studies with this additional herbicidal mode-of-action now identified.

Thiocyanate extract has the potential to be a natural organic non-selective bioherbicide that is soil active with systemic translocated properties. Systemic activity, or the ability of the active ingredient to move from soil, to roots, and then to stem and leaves, is particularly significant given that the leading synthetic herbicide glyphosate is not soil active, and only acts on the above ground parts of the weed it contacts. MustGrow believes a tremendous opportunity exists to potentially replace or compliment glyphosate in certain systems, by providing a natural organic solution. Globally, glyphosate is being phased out, including recent announcements by Germany and Mexico by 2024. France recently announced glyphosate restrictions but stopped short of a full ban because of a lack of non-chemical alternatives.

Keep reading... Show less
  • Cannabis-Infused Beverage Category Appeals to New-to-Category Consumers as Alternate to Alcohol
  • Cann Offers Portfolio of Micro-dosed Social Tonics, Low in Calories with All-Natural Ingredients
  • Complements Green Thumb’s Brand Portfolio with Beverage Category Offering

Green Thumb Industries Inc. (“Green Thumb”) (CSE: GTII) (OTCQX: GTBIF), a leading cannabis consumer packaged goods company and owner of Rise™ Dispensaries, today announced an exclusive partnership with leading cannabis-infused beverage brand Cann to manufacture and distribute its line of cannabis-infused sparkling beverages beginning in Illinois this spring. Green Thumb and Cann will expand distribution to additional markets including New Jersey, which recently legalized adult-use cannabis sales.

“The cannabis beverage category is poised for growth. Consumers are increasingly entering the market seeking alternatives to alcohol with familiar consumption experiences,” said Green Thumb Founder and CEO Ben Kovler. “Cann sits squarely in this opportunity, delivers on the consumer need, and complements our brand portfolio with entry into the beverage segment. What’s even better is cannabis drinks can offer a superior experience, fewer calories and no hangover compared to alcohol. We are investing in the space and in the Cann team and we couldn’t be more excited to bring California’s #1 cannabis beverage brand to Illinois and beyond.”

Keep reading... Show less